A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients

Journal of Infectious Diseases

Volumn 203, Issue 7, 2011, Pages 984-991

  De Vries Sluijs, Theodora E M S ^a   Hansen, Bettina E ^a   Van Doornum, Gerard J J ^a   Kauffmann, Robert H ^b   Leyten, Eliane M S ^c   Mudrikova, Tania ^d   Brinkman, Kees ^e   Den Hollander, Jan G ^f   Kroon, Frank P ^g   Janssen, Harry L A ^a   Van Der Ende, Marchina E ^a   De Man, Robert A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HAGA City Hospital   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e University Medical Center Utrecht ^*  (Netherlands)

^f Maasstad Hospital Rotterdam   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSPNEA; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INJECTION SITE REACTION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; URTICARIA;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MEDICATION ADHERENCE; MIDDLE AGED; VACCINATION;

EID: 79953006497     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq137     Document Type: Article

References (21)

1. Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, Aberg JA. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis 2005; 41:1045-8. (Pubitemid 41368231)
2. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 2005; 23:2902-8. (Pubitemid 40386492)
3. Bruguera M, Cremades M, Salinas R, Costa J, Grau M, Sans J. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 1992; 14:27-30.
4. Carne CA, Weller IV, Waite J, et al. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br Med J (Clin Res Ed) 1987; 294:866-8. (Pubitemid 17046382)
5. Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988; 109:101-5.
6. Keet IP, van Doornum G, Safary A, Coutinho RA. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS 1992; 6:509-10.
7. Rey D, Krantz V, Partisani M, et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 2000; 18:1161-5. (Pubitemid 30001829)
8. Sasaki MG, Foccacia R, de Messias-Reason IJ. Efficacy of granulocytemacrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection. Vaccine 2003; 21:4545-9. (Pubitemid 37315774)
9. Bailey CL, Smith V, Sands M. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. Int J Infect Dis 2008; 12:e77-83.
10. Nyamathi A, Liu Y, Marfisee M, et al. Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nurs Res 2009; 58:13-22.
11. Panhotra BR, Saxena AK, Al-Hamrani HA, Al-Mulhim A. Compliance to hepatitis B vaccination and subsequent development of seroprotection among health care workers of a tertiary care center of Saudi Arabia. Am J Infect Control 2005; 33:144-50. (Pubitemid 40417929)
12. Suckling RM, Taegtmeyer M, Nguku PM, et al. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect 2006; 64:271-7. (Pubitemid 44507705)
13. Bock HL, Loscher T, Scheiermann N, et al. Accelerated schedule for hepatitis B immunization. J Travel Med 1995; 2:213-7.
14. Saltoglu N, Inal AS, Tasova Y, Kandemir O. Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity. Ann Clin Microbiol Antimicrob 2003; 2:10.
15. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006; 295:1152-60. (Pubitemid 43352345)
16. de Vries-Sluijs TE, Hansen BE, van Doornum GJ, et al. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. J Infect Dis 2008; 197:292-4. (Pubitemid 351263450)
17. Landrum ML, Huppler Hullsiek K, Ganesan A, et al. Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. Vaccine 2009; 27:4731-8.
18. Ginaldi L, De Martinis M, D'Ostilio A, et al. The immune system in the elderly: I. Specific humoral immunity. Immunol Res 1999; 20:101-8.
19. Wick G, Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 1997; 32:401-13. (Pubitemid 27366479)
20. Malaspina A, Moir S, Kottilil S, et al. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol 2003; 170:5965-72. (Pubitemid 36682576)
21. Kroon FP, Rimmelzwaan GF, Roos MT, et al. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 1998; 12:F217-23.